Rise Advisors, LLC Merrimack Pharmaceuticals Inc Transaction History

Rise Advisors, LLC

  • $207 Million
  • Q3 2024

A detailed history of Rise Advisors, LLC transactions in Merrimack Pharmaceuticals Inc stock. As of the latest transaction made, Rise Advisors, LLC holds 272 shares of MACK stock, worth $4,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares
272
Previous 272 -0.0%
Holding current value
$4,115
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 24, 2022
BUY
$3.75 - $5.1 $1,020 - $1,387
272 New
272 $1.06 Million

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email